Latest News

SPC Global launches a $100m equity raise to cut debt and reset its balance sheet, targeting leverage down to 1.1x as it accelerates its execution plan.

Hydrix wins $1-1.2m counter-drone contract with NIOA; ramp from May 2026, milestones to 2027, amid AREO capital raise and trading halt.

Argenica Therapeutics forms Clinical Advisory Committee to accelerate ARG-007 Phase 2b stroke trial.

Euro Manganese delivers positive Chvaletice PEA; post-tax NPV $492m, IRR 13.8%, payback 7.3y; phased 150ktpa HPMSM plan; feasibility by H1 2027.

EV Resources advances Tecomatlán antimony plant with dry-mill commissioning and a third-party feedstock MoU, aiming for first concentrate in H2 2026.

Bapcor trims FY26 guidance as turnaround gains momentum, capping EBITDA at $144-150m post-AASB16 amid tougher trading conditions.

Enegex kicks off 3-3.5km RC at Gogo; Tougbe AC hits 4m at 6.2g/t Au, 12m at 1.68g/t. Permit to 2027; ~$14.3m cash to fast-track West Africa drilling.

oOh!media shows 7% Q1 revenue growth; launches $12mpa pre-tax savings via an operational excellence program, with 82 job cuts.

Anteris starts US PARADIGM enrolment; US$320m funding boosts cash to US$283m as Q1 loss widens; CMS coverage boosts TAVR prospects.

Nexsen signs binding term sheet with GHK Hospital to validate and roll out rapid point-of-care diagnostics in North Asia, starting with GBS and kidney tests.

Anson inks DLE demo plant deal with POSCO for Green River, Utah; POSCO funds and operates; $7.2m fee; definitive agreement by mid-year; plant in 2027.

Neurizon gains ethics approval for NUZ-001 oral liquid Phase 1 ALS study in Australia; trial slated to start Q3 2026 and finish Q4 2026.